Xponential Fitness (XPOF) Earnings Analysis
Xponential Fitness (XPOF) next reports earnings on 2026-08-06, consensus EPS 0.09 USD. Last quarter (2026-05-07) it missed with EPS -0.04 USD vs 0.11 USD est (-136.4%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -4.42.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does XPOF next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.09 USD |
| Revenue estimate | 0.06B |
XPOF earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.04 USD | 0.11 USD | -136.4% | Miss |
| 2026-02-26 | -0.91 USD | -0.0342 USD | -2560.8% | Miss |
| 2025-11-06 | 0.34 USD | 0.14 USD | +142.9% | Beat |
| 2025-08-07 | 0.26 USD | 0.19 USD | +36.8% | Beat |
| 2025-03-13 | -0.18 USD | 0.44 USD | -140.9% | Miss |
| 2024-11-07 | -0.04 USD | 0.18 USD | -122.2% | Miss |
| 2024-08-01 | -0.03 USD | 0.19 USD | -115.8% | Miss |
Beat rate: 2/7 (29%) over reported quarters with consensus data.
XPOF valuation and analyst view
| Trailing P/E | -4.42 |
|---|---|
| Trailing EPS | -0.88863 USD |
| Price / book | -0.72 |
| Dividend yield | 0.00% |
| Market cap | 0.23B |
| Analyst consensus | Buy (8 buy / 6 hold / 0 sell) |
| Avg price target | 7 USD |
Related research pages
Frequently asked questions
When is Xponential Fitness (XPOF)'s next earnings date?
Xponential Fitness is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.09 USD and revenue estimate of 0.06B.
Did XPOF beat earnings last quarter?
In its 2026-05-07 report, XPOF posted EPS of -0.04 USD versus a 0.11 USD estimate — a miss of 136.4%.
What is XPOF's earnings track record?
Over the last 7 reported quarters with consensus data, XPOF beat estimates 2 times (29%).
What is XPOF's current P/E ratio and EPS?
XPOF trades at a trailing P/E of -4.42 on trailing EPS of -0.8886298469866281 USD.
What do analysts rate XPOF?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 7 USD.